AI assistant
Sending…
STANDARD BIOTOOLS INC. — Director's Dealing 2020
Dec 17, 2020
32853_dirs_2020-12-17_be2653dc-760f-4a0a-901f-ab2349c02b61.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2020-12-15
Reporting Person: Stankovic Ana K. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-12-15 | Common Stock | A | 8221 | — | Acquired | 8221 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-12-15 | Stock Option (Right to Buy) | $6.69 | A | 12237 | Acquired | 2030-12-15 | Common Stock (12237.0) | Direct |
Footnotes
F1: Represents Restricted Stock Units that vest in four equal annual increments beginning December 15, 2021.
F2: The Option becomes exercisable in four equal annual increments beginning on December 15, 2021.
More from STANDARD BIOTOOLS INC.
Proxy Solicitation & Information Statement
2026
Apr 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24
Regulatory Filings
2026
Feb 24
Regulatory Filings
2026
Feb 5
Regulatory Filings
2026
Jan 30